Innerbody Labs NAD+ Support combines NMN and NR in one formula. The headline 1,100 mg refers to the sum of those two precursors, not 1,100 mg of direct NAD delivered to cells.
The distinction is especially useful when comparing this product with direct-NAD capsules or a single-precursor formula. Larger combined numbers are not a clinical ranking.
The label identifies the two precursors clearly. Whether the combination improves outcomes more than either alone remains a separate evidence question.
What the serving contains
The current panel lists three capsules per serving and 30 servings: 700 mg NMN, 400 mg NR chloride, 500 mg TMG, spermidine, and black-pepper extract. Treat the complete panel as the product identity. Do not carry over the label from a review of a different brand or a plain NMN bottle.
The subscription arithmetic
The page lists $74 one-time, $59 every month, $167 every three months, and $311 every six months. The smaller monthly equivalents shown for multi-month options are rounded summaries, not the charge at each renewal. The serving-cost guide explains how to compare price per labeled serving while keeping the upfront total visible.
Is combining NMN and NR necessarily better?
Evidence that each precursor can affect NAD-related measurements does not prove that taking both together is superior. That question needs a comparison with the individual ingredients and appropriate controls. A mechanistic explanation can suggest a hypothesis; it cannot supply the missing clinical comparison. Start with NAD versus NMN versus NR.
Why the additional ingredients need review
TMG and black-pepper extract introduce questions beyond the two precursors. Ask a pharmacist to review the full label alongside medicines and other supplements rather than approving “NAD support” as an abstract category. Read TMG and methylation before assuming every NAD precursor user needs a methyl-donor add-on.
How independent is the product discussion?
A company’s explanation of its own formula is a primary source for its label and sales terms, but it is not an independent verdict on product quality. Follow research links to the original paper and identify the compound actually studied. Brand-associated editorial recommendations should be read with that commercial relationship in mind. Our editorial policy applies the same distinction to our own featured partner.
What we would compare next
Use Tru Niagen as an identifiable NR comparison and NOVOS Boost as an NMN comparison. For a more complex alternative, read ProHealth. Ask what outcome the extra ingredients are intended to improve before paying for a larger formula or longer subscription.
Sources & reading notes
Editorial source review updated September 18, 2026. Provider pages describe their own offers; inclusion does not verify a product or its results.
- Innerbody Labs: NAD+ Support Manufacturer page; related editorial content is not an independent comparison of its own product.
- Yoshino et al. (2021): NMN and muscle insulin sensitivity Small randomized study in postmenopausal women with prediabetes; not evidence for NAD injections or general weight loss.
- Martens et al. (2018): randomized oral NR crossover trial Short-term human biomarker and tolerability study; not a lifespan trial.
- Berven et al. (2023): NR-SAFE Parkinson safety trial 20 participants, four weeks; short-term safety and metabolic observations, not long-term efficacy.
- FDA: mixing medications and dietary supplements General interaction and surgery guidance; specific risks must be matched to the actual ingredient and medication.
Educational information, not individualized medical advice. We do not claim medical review or firsthand treatment experience. Read our review standards and commercial disclosure.